Device for fastening and anchoring cardiac valve prostheses

Figulla , et al. September 9, 2

Patent Grant RE45130

U.S. patent number RE45,130 [Application Number 12/213,991] was granted by the patent office on 2014-09-09 for device for fastening and anchoring cardiac valve prostheses. This patent grant is currently assigned to JenaValve Technology GmbH. The grantee listed for this patent is Christoph Damm, Markus Ferrari, Hans-Reiner Figulla, Thomas Peschel, Carsten Weber. Invention is credited to Christoph Damm, Markus Ferrari, Hans-Reiner Figulla, Thomas Peschel, Carsten Weber.


United States Patent RE45,130
Figulla ,   et al. September 9, 2014

Device for fastening and anchoring cardiac valve prostheses

Abstract

This invention relates to a device for fastening and anchoring heart valve prostheses which is essentially formed of wire-shaped interconnected elements. The aim of the invention is to be able to be implant, in a minimally invasive manner, a device of this type via the aorta by compressing the device to make it smaller, and by extending the same at the site of implantation, whereby ensuring a secure retention and a secure sealing with regard to the aorta wall. To this end, the invention provides that for fastening and supporting a cardiac valve prosthesis, three identical pairs of arched elements are interconnected, with a configuration that is offset by 120.degree., by means of solid body articulations. These solid body articulations carry out the function of pivot bearings.


Inventors: Figulla; Hans-Reiner (Jena, DE), Ferrari; Markus (Jena, DE), Weber; Carsten (Jena, DE), Peschel; Thomas (Jena, DE), Damm; Christoph (Jena, DE)
Applicant:
Name City State Country Type

Figulla; Hans-Reiner
Ferrari; Markus
Weber; Carsten
Peschel; Thomas
Damm; Christoph

Jena
Jena
Jena
Jena
Jena

N/A
N/A
N/A
N/A
N/A

DE
DE
DE
DE
DE
Assignee: JenaValve Technology GmbH (Munich, DE)
Family ID: 7633175
Appl. No.: 12/213,991
Filed: June 26, 2008
PCT Filed: February 28, 2001
PCT No.: PCT/DE01/00837
371(c)(1),(2),(4) Date: November 25, 2002
PCT Pub. No.: WO01/62189
PCT Pub. Date: August 30, 2001

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
Reissue of: 10204990 Feb 28, 2001 7198646 Apr 3, 2007

Foreign Application Priority Data

Feb 28, 2000 [DE] 100 10 074
Current U.S. Class: 623/1.15; 623/2.18; 623/900; 623/1.26
Current CPC Class: A61F 2/2418 (20130101); Y10S 623/90 (20130101); A61F 2230/0054 (20130101)
Current International Class: A61F 2/24 (20060101); A61F 2/06 (20130101)
Field of Search: ;623/2.11-2.19,1.24,1.26,900,1.15

References Cited [Referenced By]

U.S. Patent Documents
3755823 September 1973 Hancock
4106129 August 1978 Carpentier et al.
RE30912 April 1982 Hancock
4922905 May 1990 Strecker
4994077 February 1991 Dobben
5002566 March 1991 Carpentier et al.
5061277 October 1991 Carpentier et al.
5094661 March 1992 Levy et al.
5104407 April 1992 Lam et al.
5163953 November 1992 Vince
5197979 March 1993 Quintero et al.
5234456 August 1993 Silvestrini
5279612 January 1994 Eberhardt
5332402 July 1994 Teitelbaum
5336258 August 1994 Quintero et al.
5342348 August 1994 Kaplan
5352240 October 1994 Ross
5368608 November 1994 Levy et al.
5397351 March 1995 Pavcnik et al.
5411552 May 1995 Andersen et al.
5456713 October 1995 Chuter
5476508 December 1995 Amstrup
5509930 April 1996 Love
5549666 August 1996 Hata et al.
5595571 January 1997 Jaffe et al.
5613982 March 1997 Goldstein
5632778 May 1997 Goldstein
5674298 October 1997 Levy et al.
5679112 October 1997 Levy et al.
5683451 November 1997 Lenker et al.
5697972 December 1997 Kim et al.
5713953 February 1998 Vallana et al.
5746775 May 1998 Levy et al.
5755777 May 1998 Chuter
5824041 October 1998 Lenker et al.
5824080 October 1998 Lamuraglia
5840081 November 1998 Andersen et al.
5841382 November 1998 Walden et al.
5843181 December 1998 Jaffe et al.
5853419 December 1998 Imran
5855601 January 1999 Bessler et al.
5876434 March 1999 Flomenblit et al.
5880242 March 1999 Hu et al.
5899936 May 1999 Goldstein
5928281 July 1999 Huynh et al.
5935163 August 1999 Gabbay
5104407 September 1999 Lam et al.
5964798 October 1999 Imran
6001126 December 1999 Nguyen-Thien-Nhon
5061277 February 2000 Carpentier et al.
6077297 June 2000 Robinson et al.
6093530 July 2000 McIlroy et al.
6102944 August 2000 Huynh et al.
6117169 September 2000 Moe
6126685 October 2000 Lenker et al.
6146417 November 2000 Ischinger
6168614 January 2001 Andersen et al.
6177514 January 2001 Pathak et al.
6183481 February 2001 Lee et al.
6190405 February 2001 Culombo et al.
6200336 March 2001 Pavcnik et al.
6214055 April 2001 Simionescu et al.
6231602 May 2001 Carpentier et al.
6245102 June 2001 Jayaraman
6254564 July 2001 Wilk et al.
6254636 July 2001 Peredo
6283995 September 2001 Moe et al.
6287338 September 2001 Sarnowski et al.
6338740 January 2002 Carpentier
6342070 January 2002 Nguyen-Thien-Nhon
6344044 February 2002 Fulkerson et al.
6350278 February 2002 Lenker et al.
6379740 April 2002 Rinaldi et al.
6391538 May 2002 Vyavahare et al.
6425916 July 2002 Garrison et al.
6454799 September 2002 Schreck
6471723 October 2002 Ashworth et al.
6478819 November 2002 Moe
6508833 January 2003 Pavcnik et al.
6509145 January 2003 Torrianni
6521179 February 2003 Girardot et al.
6540782 April 2003 Snyders
6558417 May 2003 Peredo
6558418 May 2003 Carpentier et al.
6572642 June 2003 Rinaldi et al.
6582462 June 2003 Andersen et al.
6585766 July 2003 Huynh et al.
6613086 September 2003 Moe et al.
6626939 September 2003 Burnside et al.
6682559 January 2004 Myers et al.
6730118 May 2004 Spenser et al.
6736845 May 2004 Marquez et al.
6743252 June 2004 Bates et al.
6767362 July 2004 Schreck
6773455 August 2004 Allen et al.
6790230 September 2004 Beyersdorf et al.
6808529 October 2004 Fulkerson
6821211 November 2004 Otten et al.
6821297 November 2004 Snyders
6824970 November 2004 Vyavahare et al.
6830584 December 2004 Seguin
6861211 March 2005 Levy et al.
6872226 March 2005 Cali et al.
6881199 April 2005 Wilk et al.
6893460 May 2005 Spenser et al.
6908481 June 2005 Cribier
6911043 June 2005 Myers et al.
6945997 September 2005 Huynh et al.
6974474 December 2005 Pavcnik et al.
7014655 March 2006 Barbarash et al.
7018406 March 2006 Seguin et al.
7037333 May 2006 Myers et al.
7050276 May 2006 Nishiyama
7078163 July 2006 Torrianni
7081132 July 2006 Cook et al.
7137184 November 2006 Schreck et al.
7141064 November 2006 Scott et al.
7163556 January 2007 Xie et al.
7189259 March 2007 Simionescu et al.
7198646 April 2007 Figulla et al.
7201772 April 2007 Schwammenthal et al.
7238200 July 2007 Lee et al.
7252682 August 2007 Seguin
7267686 September 2007 DiMatteo et al.
7318278 January 2008 Zhang et al.
7318998 January 2008 Goldstein et al.
7322932 January 2008 Xie et al.
7329278 February 2008 Seguin et al.
7381218 June 2008 Schreck
7393360 July 2008 Spenser et al.
7399315 July 2008 Iobbi
7452371 November 2008 Pavcnik et al.
7473275 January 2009 Marquez
7704222 April 2010 Wilk et al.
7736327 June 2010 Wilk et al.
2001/0011187 August 2001 Pavcnik et al.
2001/0021872 September 2001 Bailey et al.
2001/0039450 November 2001 Pavcnik et al.
2002/0032481 March 2002 Gabbay
2002/0055775 May 2002 Carpentier et al.
2002/0111668 August 2002 Smith
2002/0123790 September 2002 White et al.
2002/0133226 September 2002 Marquez et al.
2002/0198594 December 2002 Schreck
2003/0027332 February 2003 Lafrance et al.
2003/0036791 February 2003 Philipp et al.
2003/0036795 February 2003 Andersen et al.
2003/0040792 February 2003 Gabbay
2003/0050694 March 2003 Yang et al.
2003/0055495 March 2003 Pease et al.
2003/0065386 April 2003 Weadock
2003/0114913 June 2003 Spenser et al.
2003/0125795 July 2003 Pavcnik et al.
2003/0130726 July 2003 Thorpe et al.
2003/0139796 July 2003 Sequin et al.
2003/0139803 July 2003 Sequin et al.
2003/0149476 August 2003 Damm et al.
2003/0153974 August 2003 Spenser et al.
2003/0195620 October 2003 Huynh et al.
2003/0236570 December 2003 Cook et al.
2004/0006380 January 2004 Buck et al.
2004/0039436 February 2004 Spenser et al.
2004/0049262 March 2004 Obermiller et al.
2004/0073289 April 2004 Hartley et al.
2004/0078950 April 2004 Schreck et al.
2004/0117004 June 2004 Osborne et al.
2004/0117009 June 2004 Cali et al.
2004/0148018 July 2004 Carpentier et al.
2004/0153145 August 2004 Simionescu et al.
2004/0186558 September 2004 Pavcnik et al.
2004/0186563 September 2004 Lobbi
2004/0186565 September 2004 Schreck
2004/0193244 September 2004 Hartley et al.
2004/0210301 October 2004 Obermiller et al.
2004/0210304 October 2004 Seguin et al.
2004/0260389 December 2004 Case et al.
2005/0009000 January 2005 Wilhelm et al.
2005/0033220 February 2005 Wilk et al.
2005/0033398 February 2005 Seguin
2005/0043790 February 2005 Seguin
2005/0049692 March 2005 Numamoto et al.
2005/0075725 April 2005 Rowe
2005/0075776 April 2005 Cho
2005/0096726 May 2005 Sequin et al.
2005/0096736 May 2005 Osse et al.
2005/0098547 May 2005 Cali et al.
2005/0113910 May 2005 Paniagua et al.
2005/0119728 June 2005 Sarac
2005/0119736 June 2005 Zilla et al.
2005/0137687 June 2005 Salahieh et al.
2005/0137688 June 2005 Salahieh et al.
2005/0137690 June 2005 Salahieh et al.
2005/0137697 June 2005 Salahieh et al.
2005/0137698 June 2005 Salahieh et al.
2005/0137702 June 2005 Haug et al.
2005/0143804 June 2005 Haverkost
2005/0143807 June 2005 Pavcnik et al.
2005/0149166 July 2005 Schaeffer et al.
2005/0150775 July 2005 Zhang et al.
2005/0171597 August 2005 Boatman et al.
2005/0171598 August 2005 Schaeffer
2005/0192665 September 2005 Spenser et al.
2005/0197695 September 2005 Stacchino et al.
2005/0222668 October 2005 Schaeffer et al.
2005/0234546 October 2005 Nugent et al.
2005/0267560 December 2005 Bates
2006/0009842 January 2006 Huynh et al.
2006/0025857 February 2006 Bergheim et al.
2006/0047343 March 2006 Oviatt et al.
2006/0058864 March 2006 Schaeffer et al.
2006/0074484 April 2006 Huber
2006/0111770 May 2006 Pavcnik et al.
2006/0142846 June 2006 Pavcnik et al.
2006/0149360 July 2006 Schwammenthal et al.
2006/0167543 July 2006 Bailey et al.
2006/0193885 August 2006 Neethling et al.
2006/0210597 September 2006 Hiles
2006/0229718 October 2006 Marquez
2006/0229719 October 2006 Marquez et al.
2006/0246584 November 2006 Covelli
2006/0259134 November 2006 Schwammenthal et al.
2006/0259136 November 2006 Nguyen et al.
2006/0265056 November 2006 Nguyen et al.
2006/0287717 December 2006 Rowe et al.
2006/0287719 December 2006 Rowe et al.
2006/0290027 December 2006 O'Connor et al.
2006/0293745 December 2006 Carpentier et al.
2007/0005129 January 2007 Damm et al.
2007/0005131 January 2007 Taylor
2007/0005132 January 2007 Simionescu et al.
2007/0020248 January 2007 Everaerts et al.
2007/0021826 January 2007 Case et al.
2007/0027535 February 2007 Purdy, Jr. et al.
2007/0038291 February 2007 Case et al.
2007/0038295 February 2007 Case et al.
2007/0043435 February 2007 Seguin et al.
2007/0050014 March 2007 Johnson
2007/0088431 April 2007 Bourang et al.
2007/0093887 April 2007 Case et al.
2007/0100435 May 2007 Case et al.
2007/0100440 May 2007 Figulla et al.
2007/0112422 May 2007 Dehdashtian
2007/0123700 May 2007 Ueda et al.
2007/0123979 May 2007 Perier et al.
2007/0142906 June 2007 Figulla et al.
2007/0162103 July 2007 Case et al.
2007/0173932 July 2007 Cali et al.
2007/0179592 August 2007 Schaeffer
2007/0185565 August 2007 Schwammenthal et al.
2007/0203576 August 2007 Lee et al.
2007/0213813 September 2007 Von Segesser et al.
2007/0239271 October 2007 Nguyen
2007/0244551 October 2007 Stobie
2007/0260327 November 2007 Case et al.
2007/0288087 December 2007 Fearnot et al.
2008/0004688 January 2008 Spenser et al.
2008/0021546 January 2008 Patz et al.
2008/0033534 February 2008 Cook et al.
2008/0065011 March 2008 Marchand et al.
2008/0071361 March 2008 Tuval et al.
2008/0071362 March 2008 Tuval et al.
2008/0071363 March 2008 Tuval et al.
2008/0071366 March 2008 Tuval et al.
2008/0071368 March 2008 Tuval et al.
2008/0071369 March 2008 Tuval et al.
2008/0077236 March 2008 Letac et al.
2008/0086205 April 2008 Gordy et al.
2008/0097586 April 2008 Pavcnik et al.
2008/0102439 May 2008 Tian et al.
2008/0133003 June 2008 Seguin et al.
2008/0140189 June 2008 Nguyen et al.
2008/0154355 June 2008 Benichou et al.
2008/0200977 August 2008 Paul et al.
2008/0215143 September 2008 Seguin
2008/0262602 October 2008 Wilk et al.
2008/0269878 October 2008 Iobbi
2008/0275549 November 2008 Rowe
Foreign Patent Documents
19546692 Jun 1997 DE
19633901 Feb 1998 DE
20003874 Jun 2000 DE
19857887 Jul 2000 DE
10010073 Sep 2001 DE
10010074 Oct 2001 DE
101 21 210 Nov 2002 DE
19546692 Nov 2002 DE
10010074 Apr 2005 DE
19857887 May 2005 DE
10010073 Dec 2005 DE
0084395 Jul 1983 EP
0458877 Aug 1990 EP
0402036 Dec 1990 EP
0402176 Dec 1990 EP
0458877 Apr 1991 EP
0515324 Nov 1992 EP
0547135 Jun 1993 EP
0871414 Sep 1995 EP
0 592 410 Oct 1995 EP
0756498 Oct 1995 EP
0 592 410 Nov 1995 EP
0786970 May 1996 EP
0729364 Sep 1996 EP
0756498 May 1997 EP
0778775 Jun 1997 EP
0786970 Aug 1997 EP
0888142 Sep 1997 EP
0971649 Oct 1998 EP
0928615 Jul 1999 EP
1051204 Jul 1999 EP
1089676 Dec 1999 EP
0986348 Mar 2000 EP
1117446 Apr 2000 EP
1 164 976 Aug 2000 EP
1158937 Sep 2000 EP
1 251 805 Oct 2000 EP
1041942 Oct 2000 EP
1041943 Oct 2000 EP
1171061 Oct 2000 EP
1206179 Feb 2001 EP
1 233 731 May 2001 EP
1117446 Jul 2001 EP
1 255 510 Aug 2001 EP
1259193 Sep 2001 EP
1 233 731 May 2002 EP
1 330 213 May 2002 EP
1206179 May 2002 EP
1347785 Aug 2002 EP
1235537 Sep 2002 EP
1248655 Oct 2002 EP
1251804 Oct 2002 EP
1257305 Nov 2002 EP
0 971 649 Dec 2002 EP
1395208 Dec 2002 EP
1 401 359 Jan 2003 EP
1406561 Jan 2003 EP
1281357 Feb 2003 EP
1408882 Feb 2003 EP
1 435 878 Apr 2003 EP
1 435 879 Apr 2003 EP
1 441 672 Jun 2003 EP
1 017 868 Sep 2003 EP
1354569 Oct 2003 EP
1494616 Oct 2003 EP
1 519 697 Jan 2004 EP
1 539 047 Apr 2004 EP
1551274 Apr 2004 EP
1 560 542 May 2004 EP
1414295 May 2004 EP
1 603 493 Sep 2004 EP
1452153 Sep 2004 EP
0987998 Oct 2004 EP
1 087 727 Nov 2004 EP
1499366 Jan 2005 EP
1 663 070 Mar 2005 EP
1 253 875 Apr 2005 EP
1 667 614 Apr 2005 EP
1 251 803 Jun 2005 EP
1 702 247 Jul 2005 EP
1734902 Aug 2005 EP
1835948 Jun 2006 EP
1863545 Sep 2006 EP
1893132 Nov 2006 EP
1901681 Dec 2006 EP
1 255 510 Mar 2007 EP
1835948 Sep 2007 EP
1112042 Nov 2007 EP
1878407 Jan 2008 EP
1886649 Feb 2008 EP
1 900 343 Mar 2008 EP
1259195 Oct 2008 EP
1994913 Nov 2008 EP
2 000 115 Dec 2008 EP
2440809 Feb 2008 GB
52-086296 Jul 1977 JP
62-227352 Oct 1987 JP
2002-525169 Aug 2002 JP
2002-536115 Oct 2002 JP
2003-523262 Aug 2003 JP
2003-524504 Aug 2003 JP
2005-118585 May 2005 JP
2007-296375 Nov 2007 JP
WO-90/09102 Aug 1990 WO
WO 91/17720 Nov 1991 WO
WO-95/24873 Sep 1995 WO
WO-95/28183 Oct 1995 WO
WO-96/13227 May 1996 WO
WO-97/32615 Sep 1997 WO
WO-98/43556 Oct 1998 WO
WO-98/46165 Oct 1998 WO
WO-99/37337 Jul 1999 WO
WO-99/66863 Dec 1999 WO
WO 00/15148 Mar 2000 WO
WO 00/18333 Apr 2000 WO
WO-00/18445 Apr 2000 WO
WO 00/25702 May 2000 WO
WO 00/047139 Aug 2000 WO
WO 00/47139 Aug 2000 WO
WO-00/53125 Sep 2000 WO
WO-00/62714 Oct 2000 WO
WO-01/10209 Feb 2001 WO
WO 01/35870 May 2001 WO
WO-01/41679 Jun 2001 WO
WO-01/51104 Jul 2001 WO
WO 01/54625 Aug 2001 WO
WO-01/58503 Aug 2001 WO
WO 01/62189 Aug 2001 WO
WO 01/64137 Sep 2001 WO
WO 02/36048 May 2002 WO
WO-02/058745 Aug 2002 WO
WO-02/100301 Dec 2002 WO
WO-02/102286 Dec 2002 WO
WO 03/003949 Jan 2003 WO
WO-03/007795 Jan 2003 WO
WO-03/009785 Feb 2003 WO
WO 03/011195 Feb 2003 WO
WO 03/013239 Feb 2003 WO
WO 03/028592 Apr 2003 WO
WO 03/047468 Jun 2003 WO
WO 00/047139 Aug 2003 WO
WO-03/079928 Oct 2003 WO
WO 03/096935 Nov 2003 WO
WO 2004/004597 Jan 2004 WO
WO 2004/016200 Feb 2004 WO
WO 2004/016201 Feb 2004 WO
WO 2004/019825 Mar 2004 WO
WO-2004/026117 Apr 2004 WO
WO 2004/026173 Apr 2004 WO
WO 2004/043301 May 2004 WO
WO 2004/082527 Sep 2004 WO
WO 2004/096100 Nov 2004 WO
WO 2005/021063 Mar 2005 WO
WO 2005/034812 Apr 2005 WO
WO 2005/062980 Jul 2005 WO
WO 2005/063980 Jul 2005 WO
WO-2005/072654 Aug 2005 WO
WO 2006/066327 Jun 2006 WO
WO-2006/066327 Jun 2006 WO
WO 2006/076890 Jul 2006 WO
WO-2006/102063 Sep 2006 WO
WO 2006/108090 Oct 2006 WO
WO 2006/124649 Nov 2006 WO
WO-2006/124649 Nov 2006 WO
WO 2006/127756 Nov 2006 WO
WO 2006/127765 Nov 2006 WO
WO-2006/132948 Dec 2006 WO
WO 2007/047488 Apr 2007 WO
WO 2007/047945 Apr 2007 WO
WO 2007/059252 May 2007 WO
WO-2007/071436 Jun 2007 WO
WO 2007/120543 Oct 2007 WO
WO-2008/028569 Mar 2008 WO
WO 2008/045949 Apr 2008 WO
WO 2008/070797 Jun 2008 WO
WO 2008/079962 Jul 2008 WO
WO 2008/101083 Aug 2008 WO

Other References

Aortenklappenbioprothese erfolgreich in der Entwicklung, (1 page) May 16, 2003. cited by applicant .
Translation of Aortenklappenbioprothese erfolgreich in der Entwicklung (2 pages). cited by applicant .
Screen shots from http://www.fraunhofer.de/presse/filme/2006/index.jsp (2 pages), 2006. cited by applicant .
Liang, Ma, et al., "Double-crowned valved stents for off-pump mitrel valve replacement," European Journal of Cardio-Thoracic Surgery, 194-198 (5 pages), Jun. 13, 2005. cited by applicant .
Huber, Christoph, et al. "Direct Access Valve Replacement (DAVR)--are we entering a new era in cardiac surgery?" European Journal of Cardio-Thoracic Surgery, 380-385, (6 pages), Jan. 19, 2006. cited by applicant .
Translation of DE 19546692 A1 (4 pages). cited by applicant .
File history for German Patent DE 195 46 692 filed Dec. 14, 1995 and patented Jul. 11, 2002. cited by applicant.

Primary Examiner: Sweet; Thomas J
Assistant Examiner: Miller; Cheryl
Attorney, Agent or Firm: Bookoff McAndrews, PLLC

Claims



The invention claimed is:

1. A device for fastening and anchoring a heart valve prosthesis, the device consisting of three identical sections, each section being coupled to adjacent sections on each side of said section by an elongated supporting ridge extending in a direction generally parallel to a longitudinal axis of the device, each section having a first arched element arched in a first direction, a second arched element arched in the first direction, and a third arched element arched in a second direction opposite from the first direction, the second and third arched elements being coupled to the first arched element at first points to define between the first and second arched elements a first space, each section further comprising a fourth arched element arched in the second direction and having ends coupled to the first arched element of said section and .[.a.]. .Iadd.the .Iaddend.first arched element of an adjacent section at second points distinct from the first points to define between the fourth arched element and the adjacent first arched elements a second space.

2. A device for supporting a heart valve prosthesis, the device consisting essentially of three substantially identical elements, each element being coupled to adjacent elements on each side of said element by an elongated supporting member extending in a direction generally parallel to a longitudinal axis of the device, each element including a first arched member coupled to, and extending in a first direction generally away from said first arched member's respective supporting members, and a second arched member coupled to the first arched member at points different from the first arched member's coupling to its respective supporting members, the second arched member extending generally in a second direction opposite from the first direction, wherein each element further includes a third arched member coupled to the first arched member at substantially the same points as the second arched member is coupled to the first arched member, the third arched member extending generally in the first direction, each element further including a pair of fourth arched members, each of said fourth arched members extending alongside, and conforming generally to, the curvature of a portion of the first arched member, each of the fourth arched members being coupled to a first arched member intermediate opposite ends of said first arched member and extending from said coupling to said first arched member generally in said second direction toward a respective supporting member.

3. The device of claim 2 wherein each fourth arched member extends to a point adjacent a respective supporting member, turns, and extends generally in the first direction, conforming generally to the curvature of a portion of a first arched member of an adjacent element on one side of said element.

4. The device of claim 3 wherein each element further includes transversal members extending between its respective supporting members.

5. The device of claim 4 wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or the heart of a wearer of the device.

6. The device of claim 4 constructed from memory metal.

7. The device of claim 3 constructed from memory metal.

8. The device of claim 2 wherein each element further includes transversal members extending between its respective supporting members.

9. The device of claim 8 wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or the heart of a wearer of the device.

10. The device of claim 8 constructed from memory metal.

11. The device of claim 2 constructed from memory metal.

.Iadd.12. A medical device, in combination with a heart valve prosthesis, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and including a collapsed mode and an expanded mode, each section including: a first arched element arched in a first direction, the first arched element disposed at a distal end of the device; a second arched element arched in the first direction, the second arched element disposed at the distal end of the device and connected to the first arched element at first points; and a fourth arched element arched in a second direction opposite from the first direction and having ends coupled to the first arched element of said section and the first arched element of an adjacent section at second points distinct from the first points to define between the fourth arched element and the adjacent first arched elements a space; wherein the heart valve prosthesis is fixedly attached to the first, second, and fourth arched elements of each of the three sections and remains fixedly attached to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device..Iaddend.

.Iadd.13. The medical device, in combination with the heart valve prosthesis of claim 12, each section further including: a third arched element arched in the second direction, the third arched element connected to the first and second arched elements at the first points..Iaddend.

.Iadd.14. The medical device, in combination with the heart valve prosthesis of claim 13, wherein each section further includes an eyelet element disposed at a proximal end of the device opposite the distal end..Iaddend.

.Iadd.15. The medical device, in combination with the heart valve prosthesis of claim 12, wherein each of the three fourth arched elements conforms generally to a curvature of a portion of the first arched element of the first section and the curvature of a portion of the first arched element of the adjacent section..Iaddend.

.Iadd.16. The medical device, in combination with the heart valve prosthesis of claim 12, wherein at least one of the second points pivots when a pressure force is exerted upon one of the first or fourth arched elements..Iaddend.

.Iadd.17. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is configured to be implanted within an aorta..Iaddend.

.Iadd.18. The medical device, in combination with the heart valve prosthesis of claim 12, wherein each section is coupled to the adjacent sections by a supporting ridge, each section further including transversal members extending between adjacent elongated supporting ridges..Iaddend.

.Iadd.19. The medical device, in combination with the heart valve prosthesis of claim 18, wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or a heart of a patient..Iaddend.

.Iadd.20. The medical device, in combination with the heart valve prosthesis of claim 18, wherein the transversal members have a saw-tooth shape..Iaddend.

.Iadd.21. The medical device, in combination with the heart valve prosthesis of claim 18, wherein the transversal members have a rhombic shape..Iaddend.

.Iadd.22. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the heart valve prosthesis is a biological heart valve prosthesis..Iaddend.

.Iadd.23. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the heart valve prosthesis is an artificial heart valve prosthesis..Iaddend.

.Iadd.24. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the three sections are spaced substantially 120 degrees apart..Iaddend.

.Iadd.25. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is constructed from memory metal..Iaddend.

.Iadd.26. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is balloon expandable..Iaddend.

.Iadd.27. A medical device, in combination with a heart valve prosthesis, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and having a first, compressed mode and a second, expanded mode, each section including: a first arched element arched in a first direction, the first arched element disposed at a distal end of the device; a third arched element arched in a second direction opposite from the first direction, the first and third arched elements connected to each other at a first point, wherein between an apex of the first arched element and an apex of the third arched element there is a space; and a fourth arched element arched in a direction opposite from the first direction and having a first end coupled to the first arched element of said section at a second point and a second end coupled to the first arched element of an adjacent section at a third point, the second point and the third point being distinct from the first point to define between the fourth arched element and the adjacent first arched elements a space; wherein the heart valve prosthesis is fixedly attached to the first and fourth arched elements of each of the three sections and remains fixedly attached to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device..Iaddend.

.Iadd.28. The medical device, in combination with the heart valve prosthesis of claim 27, wherein the first point is a pivot point about which the third arched element can move..Iaddend.

.Iadd.29. A medical device, in combination with a heart valve prosthesis fixedly attached to the medical device, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and having a first, compressed mode and a second, expanded mode, each section including: a first arched element arched in a first direction, the first arched element connected to a supporting ridge and disposed on a first, distal end of the supporting ridge; a third arched element arched in a second direction opposite from the first direction, the first and third arched elements connected to each other at a first point, wherein between an apex of the first arched element and an apex of the third arched element there is a space; and a fourth arched element arched in a direction opposite from the first direction and having ends coupled to the first arched element of said section and the first arched element of an adjacent section, wherein a curvature of the fourth arched element is different from a curvature of the third arched element; and a plurality of undulating transverse ridges connected to the supporting ridge and disposed on a second, proximal end of the supporting ridge opposite the first, distal end, such that the supporting ridge is disposed proximal to the first arched element and distal to the plurality of undulating transverse ridges, the plurality of undulating transverse ridges including at least two sets of undulating transverse ridges, each set of undulating transverse ridges extending around a circumference of the medical device; wherein the heart valve prosthesis remains fixedly attached to the medical device to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device..Iaddend.

.Iadd.30. The medical device, in combination with a heart valve prosthesis of claim 29, further including an eyelet element connected to at least one of the plurality of undulating transverse ridges..Iaddend.

.Iadd.31. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges form a supporting body configured to engage a portion of a vessel wall when the medical device is in the expanded mode at a deployed state..Iaddend.

.Iadd.32. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is configured to be implanted within an aorta..Iaddend.

.Iadd.33. The medical device, in combination with a heart valve prosthesis of claim 29, wherein at least one of the plurality of undulating transverse ridges includes tips to facilitate anchoring of the device into tissue of a vessel or a heart of a patient..Iaddend.

.Iadd.34. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges have a saw-tooth shape..Iaddend.

.Iadd.35. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges have a rhombic shape..Iaddend.

.Iadd.36. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the heart valve prosthesis is a biological heart valve prosthesis..Iaddend.

.Iadd.37. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the heart valve prosthesis is an artificial heart valve prosthesis..Iaddend.

.Iadd.38. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the three sections are spaced substantially 120 degrees apart..Iaddend.

.Iadd.39. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is constructed from memory metal..Iaddend.

.Iadd.40. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is balloon expandable..Iaddend.
Description



CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a U.S. national counterpart application of international application serial no. PCT/DE01/00837 filed Feb. 28, 2001, which claims priority to German application serial No. 100 10 074.0 filed Feb. 28, 2000.

BACKGROUND AND SUMMARY OF THE INVENTION

The invention relates to a device for fastening and anchoring cardiac valve prostheses which is essentially formed of wire-shaped interconnected elements. In the folded up state it is allowed to be introduced through the aorta in a minimally invasive manner, and be anchored in the aorta wall after being deployed such that the implanted and secured heart valve prosthesis is allowed to adopt the function of the endogenous heart valve.

Heretofore, it did not succeed in a satisfactory extent to suggest a solution wherein both a secure sealing against the aorta wall and a secure retention can be ensured. On that occasion, such a device or such an anchoring support (stent) must be able to be folded up small enough in order to be stretched then at the site of implantation. With the known solutions a satisfactory enlargement will not be achieved with the appropriate tension force which is allowed to ensure such a retention. Proposals in which a form storage metal (memory metal) is to be used as well do not meet the requirements although an expansion takes place with these materials when a transition temperature has been reached and exceeded, respectively.

The solution as described in U.S. Pat. No. 5,411,552 cannot meet the requirements as well since a relatively instable object is to be used.

Another problem which is solved in an unsatisfactory manner so far is the secure attachment of an artificial or biological heart valve prosthesis. As a rule, the prostheses are lavishly sewn on to a stent. This is time-consuming and has to be carried out with great care in order to avoid damages.

Since the implanted heart valve prostheses have to be able to function over long periods the constructional design plays an essential role as well since damages and leakages can occur after the implantation otherwise which can result in life threatening states of the patient.

Hence, it is an object of the invention to suggest a device for fastening and anchoring heart valve prostheses which can be folded up small enough, and deployed at the site of implantation for a minimally invasive implantation through the aorta wherein a secure retention and a secure sealing with respect to the aorta wall are ensured.

According to the invention this object is solved with a device according to claim 1.

Advantageous embodiments and improvements of the invention can be achieved with the features mentioned in the subclaims.

Three identical pairs of arched elements each are substantial elements of the solution according to the invention which are interconnected in a configuration that is offset by 120.degree.. The two arched elements of one pair are bent opposite to each other in a curved manner and connected by means of solid articulations. The solid articulations simultaneously meet the function of pivot bearings about which the arched elements of one pair can be swivelled similarly as with a seesaw. If a pressure force is exerted upon one of the arched elements, e.g. through the peristaltic action of the aorta, this arched element will be swivelled according to the same direction about the axis of rotation on the solid articulation. Simultaneously, the respective other arched element of the pair will be swivelled opposite thereto. Therefore, one of the two arched elements of the pair is then already pressed against the aorta wall increasing the sealing and the retention.

It is favourable to dimension the arched elements of a pair such that as far as possible the same lever relations are met with respect to the solid articulations forming the pivot bearings, thus rocker arms with an identical length or at least with approximately the same length will be formed.

The relative great distances of the solid articulations predetermined by the configuration of 120.degree. of the pairs of arched elements, and the large surface areas covered by the arched elements as well are also advantageous wherein the distal arched elements do not only serve for fastening the heart valve prosthesis but also adopt a supporting function.

The mentioned advantages can still be improved by means of another curved arched element which is arranged in the distal direction.

On that occasion, the second distal arched element in its distal area is designed in a curved manner approximately like the first distal arched element. Partly, these two arched elements are designed and shaped such that they pass adjacent to each other, and gaps are formed between them. They are allowed to be interconnected at the same place at which the solid articulations are also arranged as a connection toward the arched element curved in the proximal direction. Hence, the formed gaps are open in the distal direction, and portions of the heart valve prosthesis are allowed to be introduced into the gaps and be supported.

At least one portion of a distal arched element is proximally retracted and guided up to a turning point in which adjacent arched elements are collected. With two distally arranged arched elements this applies to the respective distally outer arched element.

For stiffening and as a further possibility of fastening the heart valve prosthesis it is allowed to use an angular curved arched element being proximally retracted as well, the curved portions of which are located between the respective adjacent arched elements and are formed partly following the respective curvature. These arched elements with the distal ends thereof are secured to the one distally outer arched element or the respective distally outer arched element. Herein, the attachment also forms a respective solid articulation. These should still be located in a distance to the other solid articulations connecting one pair.

With a device being implanted and stretched over the pockets of a heart valve prosthesis then can be pushed in, held and supported there.

The construction of the arched element of the device according to the invention supports a heart valve prosthesis in a large-surface manner, and therefore with care. Additionally, it is allowed to be fastened with a substantially lower amount, for example by sewing.

The constructional solution enables a secure retention and the required sealing on the aorta wall, and with respect thereto, respectively. Pressing against the heart valve prosthesis from the inside by means of the arched element is advantageous for the sealing and for a reduced load of the heart valve prosthesis.

The device according to the invention can be implanted by means of a balloon catheter and can be deployed at the site of implatation. Advantageously, for the device is used a form storage metal as well having a suitable transition temperature by means of which an extension can be additionally achieved. For this, an alloy containing nickel and titanium can be employed which is available under the designation of Nitinol.

Moreover, the portion of the device supporting and holding the heart valve prosthesis can be implanted separately to a supporting body which is still referred to hereinafter with the description of an embodiment without reducing the advantageous properties. The implantation of this portion substantially consisting of the three segments having the heart valve prosthesis attached thereto then can operatively take place in a conventional form.

In the text that follows, the invention will be explained in more detail according to an embodiment in which

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a developed view of an embodiment of a device according to the invention.

DETAILED DESCRIPTION OF THE DRAWINGS

In FIG. 1 is shown a developed view of an embodiment of a device according to the invention. The device is radially symmetrically designed wherein three identical portions are used in a configuration of 120.degree..

Each portion uses an arched element construction as a carrier and for fastening an artificial or biological heart valve prosthesis.

With this embodiment two arched elements 4 and 5 are used which are distally arranged outside wherein the outer arched element 5 could be abandoned as the case may be.

The arched element 4 bent into a curved manner is connected to an arched element 3 which is bent in the opposite direction. The two sided connections represent solid articulations 7 which simultaneously adopt pivot functions for the two arched elements 3 and 4 representing levers as it is already described in the general part of the description.

The second arched element 3 which is outwardly bent and distally arranged increases the stability and offers an additional supporting and fastening possibility for the heart valve prosthesis. On that occasion, the two distally outer arched elements 4 and 5 are interconnected as well, wherein this connection is allowed to occur at the same place at which the solid articulations 7 are also arranged.

There are gaps between the two arched elements 4 and 5 which are open from the distal direction into which the portions of the heart valve prosthesis can be introduced and fixed there.

The arched element 5 being the outer one here is further inwardly pulled in the proximal direction, and is connected with its end to a respective supporting ridge 8. In this embodiment, the supporting ridges 8 are aligned in parallel to the longitudinal axis of the device, and together with saw tooth shaped, rhombic or meander shaped transversal ridges they form a supporting body which in the deployed state closely fits on the aorta wall. For interlocking, additional tips 9 can be present and designed, respectively, on the supporting ridges 8, and/or the transversal ridges which interlock in the aorta wall.

The configuration and length of the supporting ridges 8, and the respective great distance toward the heart valve prosthesis fastened in the area of the arched elements 3, 4 and 5 enable positioning the heart valve prosthesis without locking and covering the coronary vessels, respectively.

With the embodiment as shown herein, additional arched elements 2 being proximally pulled in are present between the individual segments used in a configuration of 120.degree. which are connected to the distally outer arched elements 5. Herein, the connections are solid articulations 6 as well, however, which should be arranged in a distance toward the solid articulations 7 as far as possible. Thus, two levers per segment can be used, and forces twice as large can be realized with such a double-reflected structure in order to fix the device.

In the deployed implanted state the portions of the heart valve prosthesis can be mutually introduced in turn between the portions 1 of the arched elements 5 and the arched elements 2, thus being supported and fixed thereto.

The number of the arched elements used can still be increased, however, to improve the retention and to further decrease the load of the heart valve prosthesis.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed